Share Price and Basic Stock Data
Last Updated: December 31, 2025, 8:57 pm
| PEG Ratio | 57.43 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Andrew Yule & Company Ltd operates in the Plantations sector, specifically focusing on tea and coffee production. As of the latest reporting, the company’s share price stood at ₹23.0, with a market capitalization of ₹1,127 Cr. Over the past several quarters, the company’s sales have demonstrated considerable volatility. In September 2022, sales were ₹116.07 Cr, peaking at ₹119.98 Cr in December 2022, before declining to ₹58.58 Cr by June 2023. The latest quarter reported sales of ₹87.99 Cr in September 2023, indicating some recovery but still below the December 2022 peak. Yearly sales figures show a decline from ₹414 Cr in March 2022 to ₹374 Cr in March 2023, with projections for March 2024 indicating further contraction to ₹310 Cr. This downward trend raises concerns regarding demand and operational efficiency in a competitive market, particularly as the company grapples with fluctuating commodity prices and changing consumer preferences.
Profitability and Efficiency Metrics
Profitability metrics for Andrew Yule & Company Ltd have been a significant concern. The company reported an Operating Profit Margin (OPM) of -6.45% as of the latest quarter, with consecutive quarters reflecting negative margins, notably plunging to -35.52% in June 2023 and -24.57% in December 2023. The net profit for the quarter ending September 2023 was recorded at a loss of ₹5.27 Cr, highlighting ongoing challenges. The company’s Return on Equity (ROE) stood at 7.96%, which, while positive, is overshadowed by the low Return on Capital Employed (ROCE) of 6.83%. The interest coverage ratio (ICR) of 0.00x indicates that the company is currently unable to meet its interest obligations, which is a critical red flag for investors. The operating profit has consistently shown negative figures over multiple quarters, with the most alarming drop occurring in March 2024, where a loss of ₹35.14 Cr was reported.
Balance Sheet Strength and Financial Ratios
Andrew Yule & Company’s balance sheet reflects a precarious financial position. Total borrowings stood at ₹120 Cr against reserves of ₹264 Cr, indicating a debt-to-equity ratio of 0.31x, which, while manageable, raises concerns given the company’s profitability challenges. The company’s current ratio is 0.66x, suggesting liquidity issues as it falls below the acceptable threshold of 1.0. Furthermore, the quick ratio of 0.55x reinforces this liquidity concern, indicating that the company may struggle to cover its short-term liabilities. The book value per share has slightly declined to ₹6.93 in March 2025 from ₹7.87 in March 2023, reflecting erosion in shareholder equity. The enterprise value (EV) of ₹1,325.93 Cr, compared to the net operating revenue of ₹294 Cr, suggests a high valuation relative to its revenue generation capability. These financial ratios point towards a company in distress, emphasizing the need for strategic financial management and operational efficiency improvements.
Shareholding Pattern and Investor Confidence
The shareholding structure of Andrew Yule & Company Ltd reveals strong promoter control, with promoters holding 89.25% of the total shares, which offers stability but limits public participation. Foreign Institutional Investors (FIIs) have shown negligible interest, with their stake recorded at 0.00% as of December 2023, indicating a lack of confidence from international investors. Domestic Institutional Investors (DIIs) hold a modest 2.20%, reflecting limited institutional backing. The public shareholding comprises 8.55%, with the number of shareholders rising to 47,115 as of September 2025, suggesting a slight increase in retail interest. However, the concentration of ownership with promoters may deter broader investment due to perceived governance risks. The lack of significant institutional investment, combined with declining profitability, could lead to challenges in raising capital for future growth initiatives, further impacting investor sentiment.
Outlook, Risks, and Final Insight
Looking ahead, Andrew Yule & Company Ltd faces several risks that could impact its operational viability. The persistent negative operating margins and inability to cover interest expenses pose significant threats to financial stability. Additionally, the company’s declining sales figures and profitability metrics indicate operational inefficiencies that must be addressed. On the flip side, the strong promoter backing and a stable reserve position present some strengths, offering potential for restructuring and strategic pivots. The company needs to implement cost control measures and improve its operational efficiency to navigate these challenges successfully. If the company can stabilize its profitability and improve cash flow management, it may attract increased investor interest and regain market confidence. However, failure to address these operational challenges could lead to further declines in market position and profitability.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Goodricke Group Ltd | 371 Cr. | 172 | 295/162 | 149 | 0.00 % | 3.22 % | 2.86 % | 10.0 | |
| Diana Tea Company Ltd | 42.0 Cr. | 28.0 | 43.8/23.3 | 47.3 | 0.00 % | 1.40 % | 7.16 % | 5.00 | |
| Bengal Tea & Fabrics Ltd | 128 Cr. | 142 | 185/126 | 24.9 | 223 | 1.06 % | 5.22 % | 55.3 % | 10.0 |
| Bansisons Tea Industries Ltd | 9.84 Cr. | 15.6 | 15.6/5.60 | 9.42 | 0.00 % | 1.01 % | 1.01 % | 10.0 | |
| B&A Ltd | 126 Cr. | 405 | 689/354 | 13.4 | 528 | 0.00 % | 8.96 % | 6.02 % | 10.0 |
| Industry Average | 9,068.47 Cr | 411.26 | 75.33 | 265.00 | 0.41% | 7.88% | 16.74% | 7.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 116.07 | 119.98 | 81.14 | 58.58 | 87.99 | 86.72 | 76.57 | 55.53 | 89.42 | 68.33 | 98.43 | 56.14 | 71.52 |
| Expenses | 94.13 | 114.18 | 97.55 | 79.39 | 100.16 | 108.03 | 111.71 | 67.28 | 79.34 | 88.00 | 140.66 | 83.80 | 76.13 |
| Operating Profit | 21.94 | 5.80 | -16.41 | -20.81 | -12.17 | -21.31 | -35.14 | -11.75 | 10.08 | -19.67 | -42.23 | -27.66 | -4.61 |
| OPM % | 18.90% | 4.83% | -20.22% | -35.52% | -13.83% | -24.57% | -45.89% | -21.16% | 11.27% | -28.79% | -42.90% | -49.27% | -6.45% |
| Other Income | 10.86 | 8.68 | 9.03 | 10.01 | 7.58 | 11.67 | 8.81 | 5.23 | 11.14 | 10.36 | 36.82 | 59.71 | 11.00 |
| Interest | 2.12 | 2.76 | 2.86 | 3.25 | 3.18 | 4.31 | 4.76 | 4.62 | 5.07 | 4.36 | -7.48 | 4.99 | 4.41 |
| Depreciation | 1.77 | 1.44 | 1.97 | 1.90 | 1.46 | 1.39 | 2.20 | 1.52 | 1.60 | 1.67 | 17.13 | 1.52 | 1.61 |
| Profit before tax | 28.91 | 10.28 | -12.21 | -15.95 | -9.23 | -15.34 | -33.29 | -12.66 | 14.55 | -15.34 | -15.06 | 25.54 | 0.37 |
| Tax % | 12.80% | 54.96% | -12.61% | 0.00% | -21.34% | -13.75% | -16.49% | -2.45% | 10.72% | -9.26% | -18.53% | 7.28% | 470.27% |
| Net Profit | 20.95 | 6.99 | -5.86 | -7.51 | -5.27 | -12.48 | -22.21 | -2.67 | 14.83 | -14.40 | -0.61 | 20.14 | -0.02 |
| EPS in Rs | 0.43 | 0.14 | -0.12 | -0.15 | -0.11 | -0.26 | -0.45 | -0.05 | 0.30 | -0.29 | -0.01 | 0.41 | -0.00 |
Last Updated: December 28, 2025, 4:30 am
Below is a detailed analysis of the quarterly data for Andrew Yule & Company Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 71.52 Cr.. The value appears strong and on an upward trend. It has increased from 56.14 Cr. (Jun 2025) to 71.52 Cr., marking an increase of 15.38 Cr..
- For Expenses, as of Sep 2025, the value is 76.13 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 83.80 Cr. (Jun 2025) to 76.13 Cr., marking a decrease of 7.67 Cr..
- For Operating Profit, as of Sep 2025, the value is -4.61 Cr.. The value appears strong and on an upward trend. It has increased from -27.66 Cr. (Jun 2025) to -4.61 Cr., marking an increase of 23.05 Cr..
- For OPM %, as of Sep 2025, the value is -6.45%. The value appears strong and on an upward trend. It has increased from -49.27% (Jun 2025) to -6.45%, marking an increase of 42.82%.
- For Other Income, as of Sep 2025, the value is 11.00 Cr.. The value appears to be declining and may need further review. It has decreased from 59.71 Cr. (Jun 2025) to 11.00 Cr., marking a decrease of 48.71 Cr..
- For Interest, as of Sep 2025, the value is 4.41 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.99 Cr. (Jun 2025) to 4.41 Cr., marking a decrease of 0.58 Cr..
- For Depreciation, as of Sep 2025, the value is 1.61 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.52 Cr. (Jun 2025) to 1.61 Cr., marking an increase of 0.09 Cr..
- For Profit before tax, as of Sep 2025, the value is 0.37 Cr.. The value appears to be declining and may need further review. It has decreased from 25.54 Cr. (Jun 2025) to 0.37 Cr., marking a decrease of 25.17 Cr..
- For Tax %, as of Sep 2025, the value is 470.27%. The value appears to be increasing, which may not be favorable. It has increased from 7.28% (Jun 2025) to 470.27%, marking an increase of 462.99%.
- For Net Profit, as of Sep 2025, the value is -0.02 Cr.. The value appears to be declining and may need further review. It has decreased from 20.14 Cr. (Jun 2025) to -0.02 Cr., marking a decrease of 20.16 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.00. The value appears to be declining and may need further review. It has decreased from 0.41 (Jun 2025) to 0.00, marking a decrease of 0.41.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:14 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 382 | 372 | 385 | 421 | 367 | 312 | 299 | 330 | 414 | 374 | 310 | 311 | 294 |
| Expenses | 350 | 386 | 381 | 409 | 362 | 330 | 336 | 332 | 423 | 380 | 399 | 374 | 389 |
| Operating Profit | 32 | -14 | 4 | 12 | 6 | -19 | -37 | -2 | -8 | -6 | -89 | -64 | -94 |
| OPM % | 8% | -4% | 1% | 3% | 2% | -6% | -12% | -0% | -2% | -2% | -29% | -20% | -32% |
| Other Income | 11 | 46 | 22 | 42 | 28 | 40 | 29 | 31 | 34 | 32 | 38 | 64 | 118 |
| Interest | 12 | 11 | 10 | 9 | 7 | 6 | 8 | 8 | 8 | 10 | 16 | 22 | 6 |
| Depreciation | 5 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 6 | 6 | 7 | 7 | 22 |
| Profit before tax | 26 | 14 | 10 | 38 | 20 | 7 | -23 | 14 | 11 | 9 | -74 | -29 | -4 |
| Tax % | 12% | 7% | 11% | 16% | 32% | 24% | -5% | -46% | 109% | 87% | -13% | -10% | |
| Net Profit | 35 | 46 | 21 | 45 | 22 | 6 | -22 | 35 | -5 | 13 | -47 | -3 | 5 |
| EPS in Rs | 1.08 | 1.38 | 0.63 | 0.93 | 0.46 | 0.11 | -0.44 | 0.72 | -0.11 | 0.26 | -0.97 | -0.06 | 0.11 |
| Dividend Payout % | 0% | 7% | 0% | 11% | 9% | 0% | 0% | 0% | 0% | 3% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 31.43% | -54.35% | 114.29% | -51.11% | -72.73% | -466.67% | 259.09% | -114.29% | 360.00% | -461.54% | 93.62% |
| Change in YoY Net Profit Growth (%) | 0.00% | -85.78% | 168.63% | -165.40% | -21.62% | -393.94% | 725.76% | -373.38% | 474.29% | -821.54% | 555.16% |
Andrew Yule & Company Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | 1% |
| 3 Years: | -9% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -3% |
| 3 Years: | % |
| TTM: | 147% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 14% |
| 3 Years: | 8% |
| 1 Year: | -45% |
| Return on Equity | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -2% |
| 3 Years: | -6% |
| Last Year: | -8% |
Last Updated: September 5, 2025, 2:16 pm
Balance Sheet
Last Updated: December 4, 2025, 2:22 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 65 | 67 | 67 | 98 | 98 | 98 | 98 | 98 | 98 | 98 | 98 | 98 | 98 |
| Reserves | 239 | 278 | 299 | 238 | 257 | 253 | 245 | 281 | 276 | 287 | 242 | 241 | 264 |
| Borrowings | 94 | 98 | 88 | 41 | 28 | 53 | 81 | 70 | 67 | 100 | 114 | 105 | 120 |
| Other Liabilities | 178 | 189 | 187 | 212 | 187 | 187 | 179 | 187 | 197 | 257 | 257 | 308 | 273 |
| Total Liabilities | 576 | 631 | 641 | 589 | 570 | 591 | 602 | 636 | 638 | 742 | 711 | 752 | 755 |
| Fixed Assets | 181 | 183 | 186 | 81 | 85 | 87 | 94 | 103 | 112 | 142 | 162 | 192 | 191 |
| CWIP | 6 | 5 | 1 | 18 | 37 | 59 | 77 | 75 | 82 | 94 | 88 | 61 | 63 |
| Investments | 97 | 131 | 143 | 169 | 179 | 179 | 202 | 203 | 197 | 201 | 219 | 244 | 240 |
| Other Assets | 292 | 313 | 311 | 321 | 270 | 265 | 228 | 255 | 247 | 305 | 242 | 256 | 261 |
| Total Assets | 576 | 631 | 641 | 589 | 570 | 591 | 602 | 636 | 638 | 742 | 711 | 752 | 755 |
Below is a detailed analysis of the balance sheet data for Andrew Yule & Company Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 98.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 98.00 Cr..
- For Reserves, as of Sep 2025, the value is 264.00 Cr.. The value appears strong and on an upward trend. It has increased from 241.00 Cr. (Mar 2025) to 264.00 Cr., marking an increase of 23.00 Cr..
- For Borrowings, as of Sep 2025, the value is 120.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 105.00 Cr. (Mar 2025) to 120.00 Cr., marking an increase of 15.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 273.00 Cr.. The value appears to be improving (decreasing). It has decreased from 308.00 Cr. (Mar 2025) to 273.00 Cr., marking a decrease of 35.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 755.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 752.00 Cr. (Mar 2025) to 755.00 Cr., marking an increase of 3.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 191.00 Cr.. The value appears to be declining and may need further review. It has decreased from 192.00 Cr. (Mar 2025) to 191.00 Cr., marking a decrease of 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 63.00 Cr.. The value appears strong and on an upward trend. It has increased from 61.00 Cr. (Mar 2025) to 63.00 Cr., marking an increase of 2.00 Cr..
- For Investments, as of Sep 2025, the value is 240.00 Cr.. The value appears to be declining and may need further review. It has decreased from 244.00 Cr. (Mar 2025) to 240.00 Cr., marking a decrease of 4.00 Cr..
- For Other Assets, as of Sep 2025, the value is 261.00 Cr.. The value appears strong and on an upward trend. It has increased from 256.00 Cr. (Mar 2025) to 261.00 Cr., marking an increase of 5.00 Cr..
- For Total Assets, as of Sep 2025, the value is 755.00 Cr.. The value appears strong and on an upward trend. It has increased from 752.00 Cr. (Mar 2025) to 755.00 Cr., marking an increase of 3.00 Cr..
Notably, the Reserves (264.00 Cr.) exceed the Borrowings (120.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -62.00 | -112.00 | -84.00 | -29.00 | -22.00 | -72.00 | -118.00 | -72.00 | -75.00 | -106.00 | -203.00 | -169.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 96 | 107 | 103 | 103 | 79 | 79 | 62 | 70 | 70 | 115 | 118 | 146 |
| Inventory Days | 131 | 104 | 132 | 106 | 156 | 203 | 201 | 185 | 193 | 155 | 109 | 134 |
| Days Payable | 301 | 250 | 281 | 223 | 212 | 227 | 223 | 252 | 231 | 304 | 246 | 351 |
| Cash Conversion Cycle | -74 | -40 | -46 | -15 | 23 | 55 | 40 | 2 | 32 | -33 | -19 | -71 |
| Working Capital Days | -25 | -41 | -27 | 16 | 1 | -26 | -87 | -54 | -10 | -53 | -154 | -187 |
| ROCE % | 10% | 6% | 4% | 7% | 7% | 2% | -4% | 5% | 9% | 4% | -14% | -7% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | -0.06 | -0.97 | 0.26 | -0.11 | 0.72 |
| Diluted EPS (Rs.) | -0.06 | -0.97 | 0.26 | -0.11 | 0.72 |
| Cash EPS (Rs.) | -0.38 | -1.17 | 0.15 | 0.11 | 0.55 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 6.93 | 6.94 | 7.87 | 7.65 | 7.74 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 6.93 | 6.94 | 7.87 | 7.65 | 7.74 |
| Revenue From Operations / Share (Rs.) | 6.38 | 6.34 | 7.65 | 8.47 | 6.76 |
| PBDIT / Share (Rs.) | 0.00 | -1.04 | 0.51 | 0.98 | 0.60 |
| PBIT / Share (Rs.) | -0.13 | -1.18 | 0.38 | 0.85 | 0.46 |
| PBT / Share (Rs.) | -0.58 | -1.50 | 0.18 | 0.22 | 0.30 |
| Net Profit / Share (Rs.) | -0.52 | -1.31 | 0.02 | -0.01 | 0.41 |
| NP After MI And SOA / Share (Rs.) | -0.05 | -0.97 | 0.25 | -0.10 | 0.71 |
| PBDIT Margin (%) | 0.00 | -16.37 | 6.79 | 11.62 | 8.91 |
| PBIT Margin (%) | -2.11 | -18.62 | 5.07 | 10.06 | 6.89 |
| PBT Margin (%) | -9.14 | -23.62 | 2.39 | 2.67 | 4.44 |
| Net Profit Margin (%) | -8.19 | -20.73 | 0.31 | -0.23 | 6.18 |
| NP After MI And SOA Margin (%) | -0.91 | -15.32 | 3.38 | -1.28 | 10.63 |
| Return on Networth / Equity (%) | -0.83 | -13.99 | 3.28 | -1.42 | 9.27 |
| Return on Capital Employeed (%) | -1.69 | -14.42 | 4.18 | 9.57 | 5.42 |
| Return On Assets (%) | -0.37 | -6.68 | 1.70 | -0.83 | 5.52 |
| Long Term Debt / Equity (X) | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 |
| Total Debt / Equity (X) | 0.31 | 0.33 | 0.25 | 0.17 | 0.18 |
| Asset Turnover Ratio (%) | 0.42 | 0.42 | 0.63 | 0.76 | 0.62 |
| Current Ratio (X) | 0.66 | 0.70 | 0.98 | 1.11 | 1.09 |
| Quick Ratio (X) | 0.55 | 0.59 | 0.80 | 0.86 | 0.87 |
| Inventory Turnover Ratio (X) | 8.38 | 2.36 | 2.57 | 1.99 | 1.88 |
| Interest Coverage Ratio (X) | 0.00 | -3.27 | 2.54 | 6.04 | 3.64 |
| Interest Coverage Ratio (Post Tax) (X) | -0.16 | -3.11 | 1.12 | 3.72 | 3.62 |
| Enterprise Value (Cr.) | 1325.93 | 1776.01 | 1039.44 | 1022.55 | 967.67 |
| EV / Net Operating Revenue (X) | 4.25 | 5.73 | 2.78 | 2.47 | 2.93 |
| EV / EBITDA (X) | -51194.25 | -35.00 | 40.90 | 21.23 | 32.85 |
| MarketCap / Net Operating Revenue (X) | 4.04 | 5.49 | 2.64 | 2.38 | 2.92 |
| Price / BV (X) | 3.71 | 5.01 | 2.57 | 2.64 | 2.55 |
| Price / Net Operating Revenue (X) | 4.04 | 5.49 | 2.64 | 2.38 | 2.92 |
| EarningsYield | 0.00 | -0.02 | 0.01 | -0.01 | 0.03 |
After reviewing the key financial ratios for Andrew Yule & Company Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -0.06. This value is below the healthy minimum of 5. It has increased from -0.97 (Mar 24) to -0.06, marking an increase of 0.91.
- For Diluted EPS (Rs.), as of Mar 25, the value is -0.06. This value is below the healthy minimum of 5. It has increased from -0.97 (Mar 24) to -0.06, marking an increase of 0.91.
- For Cash EPS (Rs.), as of Mar 25, the value is -0.38. This value is below the healthy minimum of 3. It has increased from -1.17 (Mar 24) to -0.38, marking an increase of 0.79.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 6.93. It has decreased from 6.94 (Mar 24) to 6.93, marking a decrease of 0.01.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 6.93. It has decreased from 6.94 (Mar 24) to 6.93, marking a decrease of 0.01.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 6.38. It has increased from 6.34 (Mar 24) to 6.38, marking an increase of 0.04.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 2. It has increased from -1.04 (Mar 24) to 0.00, marking an increase of 1.04.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.13. This value is below the healthy minimum of 0. It has increased from -1.18 (Mar 24) to -0.13, marking an increase of 1.05.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.58. This value is below the healthy minimum of 0. It has increased from -1.50 (Mar 24) to -0.58, marking an increase of 0.92.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -0.52. This value is below the healthy minimum of 2. It has increased from -1.31 (Mar 24) to -0.52, marking an increase of 0.79.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -0.05. This value is below the healthy minimum of 2. It has increased from -0.97 (Mar 24) to -0.05, marking an increase of 0.92.
- For PBDIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -16.37 (Mar 24) to 0.00, marking an increase of 16.37.
- For PBIT Margin (%), as of Mar 25, the value is -2.11. This value is below the healthy minimum of 10. It has increased from -18.62 (Mar 24) to -2.11, marking an increase of 16.51.
- For PBT Margin (%), as of Mar 25, the value is -9.14. This value is below the healthy minimum of 10. It has increased from -23.62 (Mar 24) to -9.14, marking an increase of 14.48.
- For Net Profit Margin (%), as of Mar 25, the value is -8.19. This value is below the healthy minimum of 5. It has increased from -20.73 (Mar 24) to -8.19, marking an increase of 12.54.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -0.91. This value is below the healthy minimum of 8. It has increased from -15.32 (Mar 24) to -0.91, marking an increase of 14.41.
- For Return on Networth / Equity (%), as of Mar 25, the value is -0.83. This value is below the healthy minimum of 15. It has increased from -13.99 (Mar 24) to -0.83, marking an increase of 13.16.
- For Return on Capital Employeed (%), as of Mar 25, the value is -1.69. This value is below the healthy minimum of 10. It has increased from -14.42 (Mar 24) to -1.69, marking an increase of 12.73.
- For Return On Assets (%), as of Mar 25, the value is -0.37. This value is below the healthy minimum of 5. It has increased from -6.68 (Mar 24) to -0.37, marking an increase of 6.31.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.31. This value is within the healthy range. It has decreased from 0.33 (Mar 24) to 0.31, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.42. There is no change compared to the previous period (Mar 24) which recorded 0.42.
- For Current Ratio (X), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 1.5. It has decreased from 0.70 (Mar 24) to 0.66, marking a decrease of 0.04.
- For Quick Ratio (X), as of Mar 25, the value is 0.55. This value is below the healthy minimum of 1. It has decreased from 0.59 (Mar 24) to 0.55, marking a decrease of 0.04.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.38. This value exceeds the healthy maximum of 8. It has increased from 2.36 (Mar 24) to 8.38, marking an increase of 6.02.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 3. It has increased from -3.27 (Mar 24) to 0.00, marking an increase of 3.27.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -0.16. This value is below the healthy minimum of 3. It has increased from -3.11 (Mar 24) to -0.16, marking an increase of 2.95.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,325.93. It has decreased from 1,776.01 (Mar 24) to 1,325.93, marking a decrease of 450.08.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.25. This value exceeds the healthy maximum of 3. It has decreased from 5.73 (Mar 24) to 4.25, marking a decrease of 1.48.
- For EV / EBITDA (X), as of Mar 25, the value is -51,194.25. This value is below the healthy minimum of 5. It has decreased from -35.00 (Mar 24) to -51,194.25, marking a decrease of 51,159.25.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.04. This value exceeds the healthy maximum of 3. It has decreased from 5.49 (Mar 24) to 4.04, marking a decrease of 1.45.
- For Price / BV (X), as of Mar 25, the value is 3.71. This value exceeds the healthy maximum of 3. It has decreased from 5.01 (Mar 24) to 3.71, marking a decrease of 1.30.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.04. This value exceeds the healthy maximum of 3. It has decreased from 5.49 (Mar 24) to 4.04, marking a decrease of 1.45.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has increased from -0.02 (Mar 24) to 0.00, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Andrew Yule & Company Ltd:
- Net Profit Margin: -8.19%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -1.69% (Industry Average ROCE: 7.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -0.83% (Industry Average ROE: 16.74%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -0.16
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.55
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 233 (Industry average Stock P/E: 75.33)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.31
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -8.19%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Plantations - Tea & Coffee | Yule House, Kolkata West Bengal 700001 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ananta Mohan Singh | Chairman & Managing Director |
| Mr. Sanjay Verma | Director - Finance |
| Mr. Sunder Pal Singh | Ind. Non-Executive Director |
| Ms. Swapna Tripathy | Ind. Non-Executive Director |
| Mr. Vijay Mittal | Nominee Director |
| Mr. Brajesh Kumar Srivastava | Nominee Director |
FAQ
What is the intrinsic value of Andrew Yule & Company Ltd?
Andrew Yule & Company Ltd's intrinsic value (as of 31 December 2025) is ₹111.84 which is 386.26% higher the current market price of ₹23.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,127 Cr. market cap, FY2025-2026 high/low of ₹43.0/22.0, reserves of ₹264 Cr, and liabilities of ₹755 Cr.
What is the Market Cap of Andrew Yule & Company Ltd?
The Market Cap of Andrew Yule & Company Ltd is 1,127 Cr..
What is the current Stock Price of Andrew Yule & Company Ltd as on 31 December 2025?
The current stock price of Andrew Yule & Company Ltd as on 31 December 2025 is ₹23.0.
What is the High / Low of Andrew Yule & Company Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Andrew Yule & Company Ltd stocks is ₹43.0/22.0.
What is the Stock P/E of Andrew Yule & Company Ltd?
The Stock P/E of Andrew Yule & Company Ltd is 233.
What is the Book Value of Andrew Yule & Company Ltd?
The Book Value of Andrew Yule & Company Ltd is 7.39.
What is the Dividend Yield of Andrew Yule & Company Ltd?
The Dividend Yield of Andrew Yule & Company Ltd is 0.00 %.
What is the ROCE of Andrew Yule & Company Ltd?
The ROCE of Andrew Yule & Company Ltd is 6.83 %.
What is the ROE of Andrew Yule & Company Ltd?
The ROE of Andrew Yule & Company Ltd is 7.96 %.
What is the Face Value of Andrew Yule & Company Ltd?
The Face Value of Andrew Yule & Company Ltd is 2.00.